Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative
(2018)
Journal Article
Li, Z., Wu, W. W., Sheng, J., Tran, P. N., Wu, M., Ranolph, A., …Strauss, D. G. (2019). Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative. Clinical Pharmacology and Therapeutics, 105(2), 466-475. https://doi.org/10.1002/cpt.1184
International Council on Harmonization S7B and E14 regulatory guidelines are sensitive but not specific for predicting which drugs are proarrhythmic. In response, the Comprehensive In Vitro Proarrhythmia Assay (CiPA) was proposed that integrates mult... Read More about Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative.